Programmed cell death detection methods: a systematic review and a categorical comparison.
Kari S, Subramanian K, Altomonte IA, Murugesan A, Yli-Harja O, Kandhavelu M. · 2022
Read Programmed cell death detection methods: a systematic review and a categorical comparison. by Kari S, Subramanian K, Altomonte IA, Murugesan A, Yli-Harja O, Kandhavelu M. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9308588.txt.
Introduction
Kari and co-authors compare methods for detecting programmed cell death. Cells can die by set programs such as apoptosis, necroptosis, and pyroptosis. Each leaves its own shape changes and marker molecules. Telling the programs apart is hard, yet it matters for cancer drug work.
The review sorts detection methods by the hallmarks and markers they read. Microscopy and blood-based tests are both covered. For each method, the team weighs the principle, uses, strengths, and limits. A side-by-side comparison aims to name the most reliable options. The authors close with ways detection could improve. Better staging of cell death, they argue, would sharpen both research and treatment design. Apoptosis, first named in 1972, remains the best-studied program.
Catalog record
| CREATOR | Kari S, Subramanian K, Altomonte IA, Murugesan A, Yli-Harja O, Kandhavelu M. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 126 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Programmed cell death detection methods: a systematic review and a categorical comparison By Sana Kari, Kumar Subramanian, Ilenia Agata Altomonte, Akshaya Murugesan, Olli Yli-Harja, Meenakshisundaram Kandhavelu Published in: Apoptosis DOI: 10.1007/s10495-022-01735-y ABSTRACT Programmed cell death is considered a key player in a variety of cellular processes that helps to regulate tissue growth, embryogenesis, cell turnover, immune response, and other biological processes. Among different types of cell death, apoptosis has been studied widely, especially in the field of cancer research to understand and analyse cellular mechanisms, and signaling pathways that control cell cycle arrest. Hallmarks of different types of cell death have been identified by following the patterns and events through microscopy. Identified biomarkers have also supported drug development to induce cell death in cancerous cells. There are various serological and microscopic techniques with advantages and limitations, that are available and are being utilized to detect and study the mechanism of cell death. The complexity of the mechanism and difficulties in distinguishing among different types of programmed cell death make it challenging to carry out the interventions and delay its progression. In this review, mechanisms of different forms of programmed cell death along with their conventional and unconventional methods of detection of have been critically reviewed systematically and categorized on the basis of morphological hallmarks and biomarkers to understand the principle, mechanism, application, advantages and disadvantages of each method. Furthermore, a very comprehensive comparative analysis has been drawn to highlight the most efficient and effective methods of detection of programmed cell death, helping researchers to make a reliable and prudent selection among the available methods of cell death assay. Conclusively, how programmed cell death detection methods can be improved and can provide information about distinctive stages of cell death detection have been discussed. INTRODUCTION In 1972, John F.R. Kerr with his colleagues formulated the concept and coined the term apoptosis during his work on hepatocytes of rat [1]. Earlier in 1885, Walther Flemming precisely described the phenomenon of programmed cell death [2]. Apoptosis is a specific form of programmed cell death which occurs in multicellular organisms under normal physiological conditions to support different biological systems including normal cell turnover, immune system, tissue homeostasis, embryonic and brain development [3]. Apoptosis is the most organized and well-recognised program of eukaryotic cell death. Other than apoptosis, necroptosis, pyroptosis, and ferroptosis are different modes of cell death. However, apoptosis, necroptosis and pyroptosis are well-understood modalities of cell death which share some common and unique pathways and so far, they are best-studied forms of programmed cell death [4]. The process of apoptosis involving many regulatory sets of gene, not only begins after detection of any abnormality in cell function but also to control the rate of cell division [5]. When apoptosis is no longer required, the intracellular death program is activated, and cells commit suicide, as the number of cells in multicellular organisms is tightly regulated [6]. The occurrence of apoptosis displays morphological changes and triggering of biochemical cascade in the cells. These morphological changes include shrinkage and condensation of cells, increased density of cytoplasm and disassembling of nuclear envelop and formation of apoptotic bodies [7]. Such morphological changes are also considered as morphological hallmarks of apoptosis, while fragmentation of DNA, protein cleavage, and protein cross-linking as biochemical hallmarks of apoptosis [8]. The distinctive feature of apoptosis is non inflammatory and non-collateral damage cell death; wherein, cell death occurs without damaging neighbouring cells, making apoptosis a silent and immunologically inert process [5]. However, necroptosis and pyroptosis play the role of whistle blowers and initiate the release of alarmins and other proinflammatory signals into the cellular surroundings [4]. Necroptosis displays cytoplasmic swelling (oncosis), nuclear dehydration (pyknosis), dilation of golgi apparatus, mitochondria, endoplasmic reticulum, rupture of cell the membrane, vacuolation and spillage of cytoplasmic content on neighboring cells and considered as nonapoptotic form of cell death [9]. Secondary necrotic cells still exhibit some apoptotic features, such as condensed and fragmented nuclei (karyorhexis), loss of chromatin structure, and internucleosomal cleavage [10]. Difficulty in distinguishing between necroptotic and apoptotic cells makes the process of detection harder and challenging because both processes can occur simultaneously in the tissue or cell culture exposed to the stimulus [11]. In contrast, pyroptosis is characterized by rapid plasma membrane rupture, cytoplasmic swelling, and the release of proinflammatory intracellular contents. Pyroptosis is mechanistically and morphologically distinct from other forms of cell death stimulated by a range of microbial infections and non-infectious stimuli [12]. This review is an effort to categorise and summarise some conventional and non-conventional detection methods based on hallmarks and biomarkers of programmed cell death occurring due to intertwined cell death pathways of apoptosis, necroptosis and pyroptosis. All three modalities are so far, the most well understood and prevalent forms of cell death in multicellular organisms. PROGRAMMED CELL DEATH MECHANISM, CROSSTALK AND ITS CLINICAL IMPORTANCE Cell-death inducing program usually begins via the same basic components either to terminate a cell due to developmental sequences or immune-mediate signals triggered by death receptors which is quite an extrinsic mode of cell death, and it is also considered as cell death by social control. On the contrary, when a cell encounters oxidative stress, viral infection, or injury inflicted by DNA damaging agent, mitochondrial cytochrome c-mediated intrinsic apoptotic pathway gets triggered which is also known as autonomous cell death [13]. In apoptosis, extrinsic pathway gets triggered when a ligand produced by natural killer cells or macrophages gets attached to death receptors, Tumor necrosis factor (TNF) receptor 1, or Toll-like receptors (TLRs) present on the cell surface, which recruit intracellular adaptor proteins (FADD, RIPK1 and procaspase-8) that bind and aggregate procaspase molecules to initiate proteolytic cascade. Mitochondria gets induced and starts releasing cytochrome-c into cytosol when the cell encounters any damage or stress. Cytochrome-c binds and activates adaptor protein (apoptotic protease activating factor 1, APAF1), which recruits procaspase-9 forming the apoptosome [14]. Both the extrinsic and intrinsic pathways work in a cooperative manner to ensure health and encounter the damage and removal of cells [5]. Overall, both apoptotic pathways are based on a set of highly specific cysteine-aspartic proteases known as caspases which are divided into two categories: initiator caspases (− 2, − 6, − 8, and − 10) and executioner caspases (− 3, − 6, and − 7) [15]. This protease family possesses a cysteine at the active site and cleaves the specific aspartic acid site of the target protein. Caspases are synthesised in the cell and remain inactive and are called procaspases, which eventually get activated by cleavage at the aspartic acid site by other caspase and initiate a series of proteolytic cascade. This proteolytic cascade is a non-reversible, destructive, and self-amplifying cascade which once started, does not turnback until it terminates the cell [6]. Regulation and activation of procaspases are partially supported by Bcl-2 family of intracellular proteins. B cell lymphoma 2 (Bcl-2) is a protooncogene which, produces pro- and anti-apoptotic proteins [16]. In 1988, David L. Vaux and is colleagues discovered the anti-apoptotic and tumorigenic role of Bcl-2 [17]. Bcl-2 family of proteins is considered a powerful regulator, which regulates apoptosis through mitochondria in an apoptotic cell [18]. From Bcl-2 family, Bcl-XL, which is a homologue of Bcl-2, interacts with APAF1 to inhibit the activation